We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: NVIDIA, Moderna, Clorox, Campbell Soup and General Mills
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 15, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include NVIDIA Corp. (NVDA - Free Report) , Moderna Inc. (MRNA - Free Report) , The Clorox Co. (CLX - Free Report) , Campbell Soup Co. (CPB - Free Report) and General Mills Inc. (GIS - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Rebalance Your Portfolio to Counter Recovery Dilemmas
Wall Street witnessed an impressive rally in the past one and half month that helped all three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — to exit the bear-market territory after entering it on Mar 11 and 12, respectively. However, market volatility has heightened this week on dilemma over a quick reopening of the economy and uncertainty about a V-shaped recovery.
Concerns Over Reopening and Recovery
In the first three trading days of the week, the Dow, the S&P 500 and the Nasdaq Composite, tumbled 4.51%, 3.78% and 2.83%, respectively.
On May 12, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, stated in a Senate committee hearing that reopening the U.S. economy in a hurry could lead to more disease outbreaks and unnecessary deaths. Per Fauci, the nation could face more “suffering and death” if states start to reopen too quickly.
On May 13, during a webcast with the Peterson Institute for International Economics, Fed Chairman, Jerome Powell said that the path toward recovery from the viral outbreak will likely be a treacherous one. Powell also said that the current recession is unprecedented and likely the worst since World War II.
Moreover, geopolitical tensions between the United States and China have intensified over the coronavirus outbreak. On May 13, President Donald Trump tweeted that 100 trade deals between the United States and China will not be able to make up for the losses his country has suffered owing to "the plague from China."
Rebalance Your Portfolio
Markets stay northbound despite volatility and the worst is most likely behind us as negative estimates are already factored in valuations. However, coronavirus-led woes are persisting in the United States and globally. This may lead to indiscriminate fluctuations in stock prices in the short term. At this stage, a combination of aggressive and defensive stocks after filtering with proper selection criteria will be prudent for one's portfolio.
Invest in Growth Sector, Especially Technology Stocks
The technology sector always remains in the forefront of any Wall Street rally. The impressive performance of stock markets in the past one and half month was also set in track by this space.
The technology sector was feared widely to suffer major setbacks owing to the coronavirus-induced economic disaster. In contrast, its strong growth came as a pleasant surprise to market participants.
Meanwhile, growth stocks are associated with aggressive earnings or revenue improvements, which should propel their prices higher in the future. There are several growth stocks available in the technology sector. Notable among them is NVIDIA Corp.
Invest in Health Care Stocks That Are COVID -19 Players
The recent economic disaster and the consequent stock market turmoil globally is not the result of any economic, financial or geopolitical factor but a biological hazard in the form of coronavirus.
This makes companies, whose drug's for the treatment of COVID -19 are in clinical trials, highly attractive to investors despite the fact that the sector itself is defensive in nature. One of these stocks includes Moderna Inc.
Minimize Portfolio Risks With Low-Beta High-Yielding Stocks
Low-beta (beta value less than 1 but greater than zero) are less volatile than the broader market. During the period of stiff market downturn in February and March, several low-beta stocks have actually recorded stellar gains. Moreover, regular dividend will ensure a steady income stream.
Therefore, low-beta, high-yielding stocks will be preferred to reduce portfolio risks when volatility has become part of daily trading at least for the near term. Stocks that fulfill this criteria include The Clorox Co., Campbell Soup Co. and General Mills Inc.
Filter Stocks With Proper Selection Criteria
While all the above-mentioned companies are battling coronavirus to stay afloat, one should invest in stocks with either a Zacks Rank #1 (Strong Buy) or 2 (Buy). Stocks with a Zacks Rank #1 have beaten the market in 26 of the last 32 years with an average annual return of 24.5% per year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Second, select stocks with strong growth potential, especially with a double-digit growth rate for the rest of 2020. Third, select stocks with positive earnings estimate revisions in last 7 to 30 days. A positive earnings estimate revision during the period of coronavirus-induced turmoil highlights a solid business model and robust growth potential.
Zacks’ Single Best Pick to Double
From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This young company’s gigantic growth was hidden by low-volume trading, then cut short by the coronavirus. But its digital products stand out in a region where the internet economy has tripled since 2015 and looks to triple again by 2025.
Its stock price is already starting to resume its upward arc. The sky’s the limit! And the earlier you get in, the greater your potential gain.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: NVIDIA, Moderna, Clorox, Campbell Soup and General Mills
For Immediate Release
Chicago, IL – May 15, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include NVIDIA Corp. (NVDA - Free Report) , Moderna Inc. (MRNA - Free Report) , The Clorox Co. (CLX - Free Report) , Campbell Soup Co. (CPB - Free Report) and General Mills Inc. (GIS - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Rebalance Your Portfolio to Counter Recovery Dilemmas
Wall Street witnessed an impressive rally in the past one and half month that helped all three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — to exit the bear-market territory after entering it on Mar 11 and 12, respectively. However, market volatility has heightened this week on dilemma over a quick reopening of the economy and uncertainty about a V-shaped recovery.
Concerns Over Reopening and Recovery
In the first three trading days of the week, the Dow, the S&P 500 and the Nasdaq Composite, tumbled 4.51%, 3.78% and 2.83%, respectively.
On May 12, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, stated in a Senate committee hearing that reopening the U.S. economy in a hurry could lead to more disease outbreaks and unnecessary deaths. Per Fauci, the nation could face more “suffering and death” if states start to reopen too quickly.
On May 13, during a webcast with the Peterson Institute for International Economics, Fed Chairman, Jerome Powell said that the path toward recovery from the viral outbreak will likely be a treacherous one. Powell also said that the current recession is unprecedented and likely the worst since World War II.
Moreover, geopolitical tensions between the United States and China have intensified over the coronavirus outbreak. On May 13, President Donald Trump tweeted that 100 trade deals between the United States and China will not be able to make up for the losses his country has suffered owing to "the plague from China."
Rebalance Your Portfolio
Markets stay northbound despite volatility and the worst is most likely behind us as negative estimates are already factored in valuations. However, coronavirus-led woes are persisting in the United States and globally. This may lead to indiscriminate fluctuations in stock prices in the short term. At this stage, a combination of aggressive and defensive stocks after filtering with proper selection criteria will be prudent for one's portfolio.
Invest in Growth Sector, Especially Technology Stocks
The technology sector always remains in the forefront of any Wall Street rally. The impressive performance of stock markets in the past one and half month was also set in track by this space.
The technology sector was feared widely to suffer major setbacks owing to the coronavirus-induced economic disaster. In contrast, its strong growth came as a pleasant surprise to market participants.
Meanwhile, growth stocks are associated with aggressive earnings or revenue improvements, which should propel their prices higher in the future. There are several growth stocks available in the technology sector. Notable among them is NVIDIA Corp.
Invest in Health Care Stocks That Are COVID -19 Players
The recent economic disaster and the consequent stock market turmoil globally is not the result of any economic, financial or geopolitical factor but a biological hazard in the form of coronavirus.
This makes companies, whose drug's for the treatment of COVID -19 are in clinical trials, highly attractive to investors despite the fact that the sector itself is defensive in nature. One of these stocks includes Moderna Inc.
Minimize Portfolio Risks With Low-Beta High-Yielding Stocks
Low-beta (beta value less than 1 but greater than zero) are less volatile than the broader market. During the period of stiff market downturn in February and March, several low-beta stocks have actually recorded stellar gains. Moreover, regular dividend will ensure a steady income stream.
Therefore, low-beta, high-yielding stocks will be preferred to reduce portfolio risks when volatility has become part of daily trading at least for the near term. Stocks that fulfill this criteria include The Clorox Co., Campbell Soup Co. and General Mills Inc.
Filter Stocks With Proper Selection Criteria
While all the above-mentioned companies are battling coronavirus to stay afloat, one should invest in stocks with either a Zacks Rank #1 (Strong Buy) or 2 (Buy). Stocks with a Zacks Rank #1 have beaten the market in 26 of the last 32 years with an average annual return of 24.5% per year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Second, select stocks with strong growth potential, especially with a double-digit growth rate for the rest of 2020. Third, select stocks with positive earnings estimate revisions in last 7 to 30 days. A positive earnings estimate revision during the period of coronavirus-induced turmoil highlights a solid business model and robust growth potential.
Zacks’ Single Best Pick to Double
From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This young company’s gigantic growth was hidden by low-volume trading, then cut short by the coronavirus. But its digital products stand out in a region where the internet economy has tripled since 2015 and looks to triple again by 2025.
Its stock price is already starting to resume its upward arc. The sky’s the limit! And the earlier you get in, the greater your potential gain.
Click Here, See It Free >>
Join us on Facbook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.